Douglas Yee, MD

Professor of Medicine and Pharmacology (Joint Appointment), Division of Hematology, Oncology and Transplantation

Douglas Yee

Contact Info

Mailing Address:
Masonic Cancer Center, University of Minnesota
420 Delaware Street SE
MMC 806
Minneapolis, MN 55455

Administrative Assistant Name
Jean Jacoby

Administrative Phone

Administrative Email

Administrative Fax Number

Professor of Medicine and Pharmacology (Joint Appointment), Division of Hematology, Oncology and Transplantation

Director, Masonic Cancer Center (MCC)

Professor, Department of Pharmacology

Medical Oncologist

Medical School, University of Chicago Pritzker School of Medicine, Chicago, IL

Internal Medicine Residency, University of North Carolina, Chapel Hill, NC

Oncology Fellowship, National Cancer Institute, Medicine Branch, Bethesda, MD


Dr. Yee holds the John H. Kersey Chair in Cancer Research. He was previously co-leader of the Women's Cancer Program. He was named Director of the Masonic Cancer Center, University of Minnesota in 2007. Dr. Yee received his MD in 1981 from the University of Chicago. He received his internal medicine training and was Chief Medical Resident at the University of North Carolina. His medical oncology training was done at the National Cancer Institute in Bethesda, Maryland. Prior to coming to Minnesota, he held faculty positions at Georgetown University Medical Center and the University of Texas Health Science Center at San Antonio.


  • Breast Cancer

Awards & Recognition

  • Mpls.St. Paul Magazine "Top Doctor" (2012-2015)
  • "Best Doctors for Women," Minnesota Monthly Magazine (2011, 2014)
  • Pew Scholar in the Biomedical Sciences (1990)

Professional Associations

  • Director, Masonic Cancer Center (2007-present)
  • Tickle Family Land Grant Chair in Breast Cancer Research (1999-2009)
  • John H. Kersey Chair in Cancer Research (2008-present)
  • Komen for the Cure Scientific Advisory Council (2010)



  • Hui SK, Fairchild GR, Kidder LS, Sharma M, Bhattacharya M, Jackson S, Le C, Yee D. Skeletal remodeling following clinically relevant radiation-induced bone damage treated with zoledronic acid. Calcif Tissue Int. 2012 Jan;90(1):40-9.
  • Potter DA, Yee D, Guo Z, Rodriguez M. Should diabetic women with breast cancer have their own intervention studies? Endocr Relat Cancer. 2012 Feb 13;19(1):C13-7.
  • Becker MA, Ibrahim YH, Cui X, Lee AV, Yee D. The IGF Pathway Regulates ER{alpha} through a S6K1-Dependent Mechanism in Breast Cancer Cells. Mol Endocrinol. 2011 Mar;25(3):516-28.
  • Hui SK, Khalil A, Zhang Y, Coghill K, Le C, Dusenbery K, Froelich J, Yee D, Downs L. Longitudinal assessment of bone loss from diagnostic computed tomography scans in gynecologic cancer patients treated with chemotherapy and radiation. Am J Obstet Gynecol. 2010 Oct;203(4):353.e1-7. Epub 2010 Aug 3.PMID: 20684943
  • Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D. Diabetes and cancer: a consensus report. CA Cancer J Clin. 2010 Jul-Aug;60(4):207-21. Epub 2010 Jun 16.PMID: 20554718
  • Yee D. How to train your biomarker. Clin Cancer Res. 2010 Jun 15;16(12):3091-3. Epub 2010 Jun 8.PMID: 20530694
  • Yee D. Adaptor proteins as targets for cancer prevention. Cancer Prev Res (Phila). 2010 Mar;3(3):263-5. Epub 2010 Feb 23.PMID: 20179300
  • Zhang H, Fagan DH, Zeng X, Freeman KT, Sachdev D, Yee D. Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation. Oncogene. 2010 Apr 29;29(17):2517-27. Epub 2010 Feb 15.PMID: 20154728
  • Blaes AH, Gaillard P, Peterson BA, Yee D, Virnig B. Angiotensin converting enzyme inhibitors may be protective against cardiac complications following anthracycline chemotherapy. Breast Cancer Res Treat. 2010 Jul;122(2):585-90. Epub 2010 Jan 8.PMID: 20058065
  • Sachdev D, Zhang X, Matise I, Gaillard-Kelly M, Yee D. The type I insulin-like growth factor receptor regulates cancer metastasis independently of primary tumor growth by promoting invasion and survival. Oncogene. 2010 Jan 14;29(2):251-62. Epub 2009 Oct 19.PMID: 19838209



Breast Center

Board Certifications

  • Internal Medicine
  • Medical Oncology

Clinical Interests

Breast cancer